A Second Chance: How New AML Treatments Changed Shelley’s Life
January 15, 2026 • AML Clinical Content Hub
In the video, Shelley, a 70-year-old diagnosed with acute myeloid leukemia after her chronic myelomonocytic leukemia progressed, shares her cancer journey and how participating in a clinical trial for a targeted AML therapy helped make a successful stem cell transplant possible. She emphasizes the importance of being informed about new treatment options, the support of her daughter and medical team, and how science and perseverance gave her hope and a second chance at life.
